Moneycontrol
    Moneycontrol PRO

    Developed Bluechip Equities

    Jump to

    • US stocks rise as Venezuela ‘spillover’ seen muted; tech, energy gain

      The S&P 500 Index rose 0.6% at 9:48 a.m. in New York, while the technology-heavy Nasdaq 100 Index climbed 0.8%.

    • Indian equities lag EM peers in 2025 after five-year outperformance; DIIs cushion market volatility, shows RBI FSR

      The stability of Indian equity markets has been underpinned by strong and persistent demand from domestic institutional investors (DIIs). Their ownership of Indian equities has surpassed that of foreign investors and continues to rise, according to the RBI.

    • High valuations leading to steady supply of paper, exit window open for PEs, promoters

      High valuations across sectors are driving sustained share sales from private equity funds, promoters and the government, keeping equity supply elevated in India’s markets.

    • Overseas investments in stocks, real estate through LRS jumps over 50% to cross $2 billion in 2025

      Latest Reserve Bank of India data shows that between January and September, LRS investments in real estate grew 80% to $350 million, while remittances into equity and debt instruments rose over 50% to $1.68 billion

    • Buy Star Health; target of Rs 550: Nuvama Institutional Equities

      Nuvama Institutional Equities is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 550 in its research report dated October 04, 2025.

    • Data centres poised for explosive growth, experts see opportunities in diversifying across ecosystem

      Investors eyeing India’s data centre boom should diversify across the entire ecosystem, including renewable energy, power, real estate, telecom and technology providers, according to top money managers.

    • India to push for global carbon markets, climate finance in upcoming COP30: Bhupender Yadav

      Union environment minister Bhupender Yadav met COP30 President Andre Correa do Lago on September 1 to discuss the agenda for the upcoming climate conference to be held in Brazil in November.

    • Nuvama Wealth shares rally 4% on reports of stake sale, lower earnings hit from Jane Street crackdown

      According to reports, three PE buyout groups are in discussions with private equity company PAG to acquire the latter’s controlling stake in Nuvama Wealth Management,

    • Kotak’s Sanjeev Prasad says market valuations ignore looming economic challenges

      India’s rural consumption is improving, thanks to good monsoons in 2024 and decent crop output in the last two crop seasons (2024 kharif and 2025 rabi)

    • Adani Ports gets a "buy" rating from Kotak Institutional, sees 21% potential upside

      Kotak Institutional Equities highlighted the company’s significant deleveraging over the past five years, efficient capital deployment, and strong growth in cargo and logistics operations as key drivers of its positive outlook

    • Cement prices rise across regions in May as demand improves, says Nuvama analysts

      Cement prices have seen a broad-based increase in May 2025, led by southern states, as demand begins to firm up

    • Dollar rallies as US-China tariff truce spurs risk-on sentiment

      The Bloomberg Dollar Spot Index posted its strongest intraday gain since April 4, rising as much as one percent. The euro depreciated by up to 1.5 percent to $1.1084, marking its weakest daily performance of the year.

    • Market mispricing consumption sector, needs new valuation approach: Kotak analysts

      Kotak Institutional Equities warns that consumption stocks are being mispriced by the market, urging a reassessment of valuation frameworks due to fundamental changes in the sector

    • Still in the midst of an earnings downgrade, diversify some holding into gold: Rahul Arora of Nirmal Bang Equities

      Given the cautious outlook, Rahul Arora recommended diversifying holdings into gold, which may prove to be a strong hedge against the ongoing market volatility and uncertainty.

    • Buy StarHealth; target of Rs 440: Nuvama Institutional Equities

      Nuvama Institutional Equities is bullish on StarHealth has recommended buy rating on the stock with a target price of Rs 440 in its research report dated April 04, 2025.

    • FIIs turn buyers, retail investors turn sellers as roles reverse: Kotak Institutional Equities

      Retail investors have possibly become net sellers in the cash market on a direct basis after being perennial buyers, said Kotak Institutional Equities.

    • Laxmi Dental shares jump 5% as Nuvama initiates coverages, sees 38% upside potential

      Nuvama Institutional Equities issued a target price of Rs 570 per share, which implies a 38 percent upside for Laxmi Dental shares.

    • Recent market rally a mix of sentiment & fundamentals, but lacks value in most sectors: Kotak analysts

      Kotak analysts added Dr Lal PathLabs to their recommended portfolio, while weightings have been reduced for Indigo Aviation and Zomato

    • FMCG firms to see weak volume, value growth on muted urban demand, GCPL top bet: Kotak Institutional Equities

      Volume and value growth for consumer staples companies is likely to be weak for the next few quarters, as urban demand remains muted, weighing on sales.

    • Goldman Sachs slashes S&P 500 target after recent market rout

      While Goldman Sachs was the first to go ahead and cut its S&P 500 target, others like Citi had recently downgraded its rating for US equities to a 'neutral'.

    • Worst of FII outflows behind, their impact getting smaller, says MOFSL

      MOFSL noted that the FII exodus resulted into a mild impact on Indian equities, thanks to the counter-buying from domestic investors which held the fortress.

    • MOFSL sees buying opportunities emerge from market rout; RIL, Bharti Airtel, HUL among top picks

      MOFSL believes that Indian equities are sitting in the latter phases of its correction cycle, with muted FY25 earnings growth expected to drive double-digit uptick in FY26.

    • Kotak Institutional fears NMDC's earnings may peak in FY25, turns cautious on mining sector

      Kotak Institutional has issued a ‘Sell’ call on NMDC with a price target of Rs 55, projecting a downside of 15.4 percent from the last closing price of Rs 65 per share.

    • Indian equities' valuation premium to emerging markets normalizing, close to long-term average, says Nuvama

      Nuvama notes that India's valuation premium to emerging markets has returned to its 10-year average, suggesting the worst of the de-rating may be done.

    • Will markets find a Valentine’s Day rebound, or stay stuck in the red? Hindalco, United Breweries in focus | Market Minutes

      In today’s episode of Market Minutes, Vaibhavi Ranjan breaks down the key market movements for February 14. After seven straight days of losses, can Indian equities spark a love story with gains, or will volatility keep them heartbroken? The GIFT Nifty hints at a strong start, but key resistance levels remain a challenge. Meanwhile, Hindalco shines with a 75% surge in Q3 net profit, while United Breweries struggles with a sharp earnings decline. Global markets offer mixed signals—Wall Street cheered easing trade concerns, but Asian markets opened cautiously. In the Voice of the Day segment, Sandeep Bangla of TRUST Mutual Fund shares strategies for navigating the ongoing market slump. Stay tuned for stock insights, expert opinions, and all the latest market buzz!

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347